Skip to content

Antibiotic Prescription in Children Hospitalized for Community-acquired Pneumonia

Antibiotic Prescription in Children Hospitalized for Community-acquired Pneumonia: a Prospective, Observational Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04681339
Enrollment
200
Registered
2020-12-23
Start date
2022-09-16
Completion date
2025-12-31
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Community Acquired Pneumonia in Children, Antibiotic Stewardship

Keywords

Community acquired pneumonia, Antibiotic use, Pediatrics, Hospitalised children, Integrative medicine

Brief summary

A study to observe how often antibiotics are prescribed in children hospitalized for pneumonia and how doctors decide if a child needs antibiotics or not. Parent satisfaction will also be recorded.

Detailed description

An observational study to document the antibiotic treatment rate of children hospitalized for community acquired pneumonia at a pediatric department with longstanding practice of restrictive antibiotic prescribing. Patients will be enrolled consecutively and treated according to in-house standard operating procedure. Antibiotic treatment rate, severity of disease and medical complication rate in antibiotic and non-antibiotic managed children, frequency of predefined factors in physician decision making on antibiotic use, and parental satisfaction will be recorded. Parents will be contacted at least 4 weeks after discharge to inquire about recurrence or readmission.

Interventions

Antibiotic treatment

No antibiotic treatment

Sponsors

Gemeinschaftskrankenhaus Herdecke, Germany
CollaboratorUNKNOWN
ARCIM Institute Academic Research in Complementary and Integrative Medicine
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
3 Months to 18 Years
Healthy volunteers
No

Inclusion criteria

* Hospital admission at the pediatric department of the Filderklinik or at the pediatric department of the Herdecke Community Hospital * Admission diagnosis pneumonia or pneumonia diagnosis within 48 hours of admission * Written informed consent by care giver * All inclusion criteria have to be fulfilled

Exclusion criteria

* Insufficient knowledge of German to understand the written patient information and questionnaire

Design outcomes

Primary

MeasureTime frameDescription
Antibiotic treatment rates in hospitalized children with non-severe community-acquired pneumonia and feverDuring hospitalization, an average of 7 daysRates of treatment with and without antibiotics during hospitalization

Secondary

MeasureTime frameDescription
Factors in physician decision making on antibiotic prescriptionDuring hospitalization, an average of 7 daysPhysician questionnaire (closed-ended questions)
Parental satisfactionAt discharge, assessing the entire duration of the hospital stay, an average of 7 daysParental satisfaction questionnaire (closed-ended questions)
Hospitalization durationAt discharge, assessing the entire duration of the hospital stay, an average of 7 daysNumber of hospitalization days
Number of children with relevant comorbidityDuring hospitalization, an average of 7 daysCo-morbidities that may affect decision on antimicrobial use: a) chronic conditions (e.g. neurological conditions such as cerebral palsy, Down syndrome; or chronic respiratory conditions such as asthma, cystic fibrosis; or heart conditions). b) acute infectious comorbidities: bronchiolitis, otitis media, urinary tract infection, confirmed influenza virus or Respiratory Syncytial Virus or SARS-CoV2.
Number of medical complicationsDuring hospitalization, an average of 7 daysMedical complications defined as a) admission to intensive care, mechanical ventilation, transfer to tertiary car center OR b) pleural effusion or empyema, pneumothorax, lung abscess, bronchopleural fistula, necrotizing pneumonia, acute respiratory failure, infectious complication (meningitis, septic shock).
Use of antipyretic medicationsDuring hospitalization, an average of 7 daysNumber of doses of paracetamol or ibuprofen during hospitalization
Number of complementary medicine medications used per childDuring hospitalization, an average of 7 daysNumber of complementary medication during hospitalization
Number of readmissions for pneumonia or new pneumonia recurrences within 4 weeks of hospital discharge4 weeks after end of hospitalizationNew hospital admission for pneumonia; treatment requiring recurrence of pneumonia
Days of supplemental oxygen useDuring hospitalization, an average of 7 daysOxygen therapy for O2 saturation \<92%

Countries

Germany

Contacts

Primary ContactJan Vagedes, Dr
j.vagedes@arcim-institute.de+49 711 7703

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026